SEC Filings for Prevail Therapeutics Inc. (PRVL)

$ 15.31 0.00 (0.00%) Volume: 10 4:00 PM EDT Jul 15, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
S-3Registration statement under Securities Act of 193316107/01/2020
4Statement of changes in beneficial ownership of securities106/19/2020
4Statement of changes in beneficial ownership of securities106/19/2020
4Statement of changes in beneficial ownership of securities106/19/2020
4Statement of changes in beneficial ownership of securities106/19/2020
4Statement of changes in beneficial ownership of securities106/19/2020
4Statement of changes in beneficial ownership of securities106/19/2020
8-KCurrent report pursuant to Section 13 or 15(d)306/17/2020
3Initial statement of beneficial ownership of securities206/03/2020
4Statement of changes in beneficial ownership of securities106/03/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)8305/14/2020
8-KCurrent report pursuant to Section 13 or 15(d)805/14/2020
DEF 14AOther definitive proxy statements4304/27/2020
DEFA14AAdditional proxy soliciting materials - definitive504/27/2020
<<
First
<
Prev
12345